U.S. Physical Therapy Reports Q1 GAAP Loss and CFO Departure Amid Revenue Growth
USPH is trading near its 52-week low of $58.19 (1.9% above the low).
Summary
U.S. Physical Therapy reported a Q1 GAAP loss per share of $(0.12) due to non-cash revaluation charges, despite 7.9% revenue growth. The company also announced its CFO's resignation and a dividend increase, while detailing new strategic alliances and a $450M credit facility.
Key Events · Earnings and Guidance · USPH
-
Q1 2026 GAAP Loss Per Share
Reported a basic and diluted loss per share of $(0.12) for the three months ended March 31, 2026, compared to earnings of $0.80 in the prior-year period. Net income attributable to shareholders decreased by 49.1% to $5.0 million.
-
Revenue Growth
Net revenue increased by 7.9% to $198.3 million for Q1 2026, up from $183.8 million in Q1 2025.
-
Operating Income Decline
Operating income decreased by 36.5% to $12.5 million in Q1 2026, compared to $19.6 million in Q1 2025.
-
Non-Cash Charges Impacting EPS
The GAAP loss was significantly impacted by a $2.0 million loss on change in fair value of contingent earn-out consideration and a $9.4 million charge from the revaluation of redeemable non-controlling interests, both non-cash items.
Analysis · USPH · Industrial Applications And Services
U.S. Physical Therapy reported a significant GAAP loss per share of $(0.12) for Q1 2026, a sharp decline from $0.80 in the prior-year period. This loss was primarily driven by substantial non-cash charges related to the revaluation of contingent earn-out consideration and redeemable non-controlling interests, which increased in value due to strong underlying performance. While net revenue grew by 7.9% to $198.3 million, operating income decreased by 36.5% to $12.5 million, indicating operational pressures. The company also announced the resignation of its CFO, Carey Hendrickson, with Jason Curtis appointed as interim successor, adding a layer of uncertainty. Positively, the company increased its quarterly dividend and detailed two new 10-year strategic alliances with hospital systems, signaling continued expansion. The previously announced $450 million credit facility provides ample liquidity, but the GAAP loss and executive change are likely to be the primary focus for investors.
At the time of this filing, USPH was trading at $59.29 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $896.6M. The 52-week trading range was $58.19 to $93.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.